MedPath

The effect of expressive writing on anxiety sensitivity and severity of symptoms in patients with irritable bowel syndrome

Not Applicable
Conditions
Irritable bowel syndrome
Irritable bowel syndrome.
Registration Number
IRCT20200831048567N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
72
Inclusion Criteria

Having IBS based on a doctor's diagnosis
Satisfaction and willingness of patients to participate in the study
Having symptoms classified based on the irritable bowel syndrome Severity Index (SI-IBS); in the mild, moderate, or severe scale
The diagnosis was made at least 3 months ago
Be literate enough to write and complete questionnaires
The patient is physically and mentally fit to write
Does not suffer from acute mental disorders based on the doctor's diagnosis and registration
Does not take anti-anxiety medications for the past 3 months based on the patient's record
At the same time, participants do not have other functional or structural gastrointestinal disorders based on the patient's record

Exclusion Criteria

Diagnosis of any disease during the study by the treating physician
Patient’s dissatisfaction or unwillingness to cooperation or to continue with the study
Patients who do not participate in pre-test or post-test evaluations
Not writing in the booklet more than 2 times or a total of 4 sessions
Hospitalization of the patient due to exacerbation of gastrointestinal symptoms during the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of anxiety sensitivity. Timepoint: Before the intervention and 1 month after the intervention (written emotional expression). Method of measurement: Based on the score of (0-144) Revised Anxiety Sensitivity Index (ASI-R).;Severity of gastrointestinal symptoms. Timepoint: Before the intervention and 1 month after the intervention (written emotional expression). Method of measurement: Obtaining a score between 75-500 Based on Irritable Bowel Syndrome Severity Index (IBS-SI) Questionnaire.
Secondary Outcome Measures
NameTimeMethod
Anxiety Sensitivity Score in the Revised Anxiety Sensitivity Index (ASI-R) Questionnaire. Timepoint: Before the intervention and 1 month after the intervention. Method of measurement: Revised Anxiety Sensitivity Index (ASI-R) Questionnaire.;Gastrointestinal symptom severity score in Irritable Bowel Syndrome Severity Index (IBS-SI). Timepoint: Before the intervention and 1 month after the intervention. Method of measurement: Irritable Bowel Syndrome Severity Index (IBS-SI) Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath